These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 30279008)

  • 21. von Willebrand disease and platelet disorders.
    Favaloro EJ; Bodó I; Israels SJ; Brown SA
    Haemophilia; 2014 May; 20 Suppl 4():59-64. PubMed ID: 24762277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orthopaedic surgery in patients with von Willebrand disease.
    Siboni SM; Biguzzi E; Solimeno LP; Pasta G; Mistretta C; Mannucci PM; Peyvandi F
    Haemophilia; 2014 Jan; 20(1):133-40. PubMed ID: 23992395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular genetics of von Willebrand disease.
    Mazurier C; Ribba AS; Gaucher C; Meyer D
    Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baseline factor VIII plasma levels and age at first bleeding in patients with severe forms of von Willebrand disease.
    Siboni SM; Biguzzi E; Caiani V; Mistretta C; Bucciarelli P; Peyvandi F
    Haemophilia; 2016 Jul; 22(4):564-9. PubMed ID: 26843468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mild forms of von Willebrand disease: diagnosis and management.
    Federici AB
    Curr Hematol Rep; 2003 Sep; 2(5):373-80. PubMed ID: 12932308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. von Willebrand disease and pregnancy: a practical approach for the diagnosis and treatment.
    Pacheco LD; Costantine MM; Saade GR; Mucowski S; Hankins GD; Sciscione AC
    Am J Obstet Gynecol; 2010 Sep; 203(3):194-200. PubMed ID: 20417473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current approaches to diagnostic testing in von Willebrand Disease.
    Rao ES; Ng CJ
    Transfus Apher Sci; 2018 Aug; 57(4):463-465. PubMed ID: 30064913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis and management of von Willebrand disease in Australia.
    Favaloro EJ; Bonar R; Favaloro J; Koutts J
    Semin Thromb Hemost; 2011 Jul; 37(5):542-54. PubMed ID: 22102198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquired von Willebrand syndrome 2004: International Registry--diagnosis and management from online to bedside.
    Federici AB; Budde U; Rand JH
    Hamostaseologie; 2004 Feb; 24(1):50-5. PubMed ID: 15029273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Von Willebrand disease: screening, diagnosis, and management.
    Totonchi A; Eshraghi Y; Beck D; McCrae K; Guyuron B
    Aesthet Surg J; 2008; 28(2):189-94. PubMed ID: 19083526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. von Willebrand Disease in Pediatrics: Evaluation and Management.
    O'Brien SH; Saini S
    Hematol Oncol Clin North Am; 2019 Jun; 33(3):425-438. PubMed ID: 31030811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
    Shihong I; Morris D; Konkle BA
    Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Classification of inherited von Willebrand disease and implications in clinical practice.
    Federici AB
    Thromb Res; 2009 Nov; 124 Suppl 1():S2-6. PubMed ID: 19944257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rethinking the diagnosis of von Willebrand disease.
    Favaloro EJ
    Thromb Res; 2011 Jan; 127 Suppl 2():S17-21. PubMed ID: 21193108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Von Willebrand factor and Von Willebrand disease].
    Verhezen PW; Beckers EA; Henskens YM
    Ned Tijdschr Geneeskd; 2014; 158():A6885. PubMed ID: 24800797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet-type von Willebrand disease: a rare, often misdiagnosed and underdiagnosed bleeding disorder.
    Othman M
    Semin Thromb Hemost; 2011 Jul; 37(5):464-9. PubMed ID: 22102188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An approach to outreach patients with von Willebrand disease in Egypt by targeting women with heavy menstrual bleeding and/or bleeding symptoms.
    Sherif N; Goubran H; Hassan A; Burnouf T; El-Ekiaby M
    Haemophilia; 2014 Mar; 20(2):238-43. PubMed ID: 24251732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemophilia A and von Willebrand deficiency: therapeutic implications.
    Basso M; Lazzareschi I; Curatola A; Di Gennaro L; Buonsenso D; Gatto A; De Candia E; De Cristofaro R
    Blood Coagul Fibrinolysis; 2020 Sep; 31(6):397-401. PubMed ID: 32255574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical diagnosis of von Willebrand disease.
    Federici AB
    Haemophilia; 2004 Oct; 10 Suppl 4():169-76. PubMed ID: 15479393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.